EGFR and tuberculosis: In this study, up to 20% of the patients did not obtain successful tissue testing for EGFR and ALK. However, it is noteworthy that the sample size of the ALK and BRAF cohorts of the positive patients for comparison of TB and LB in this study was very small, and an independent validation study is now certainly mandatory to confirm the results [43].